Wellness (Dietary Supplements)
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Regulation / Legislation Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Regulation & Wellness
Why Are UK CBD Brands Pivoting Into Functional Mushroom Supplements?
Ongoing regulatory issues and restrictive marketing rules are prompting CBD brands to pivot to functional mushrooms, the market for which in the UK is predicted to reach a value of £62m by 2025. With both reportedly offering cognitive health benefits, marketing mushrooms and CBD makes good strategic sense, explains Nootro Group CEO Cary Holmes in this HBW Insight deep dive.
US FTC Says It’s On ‘Solid Ground’ To Bring Cases Following Notices Of Penalty Offense
The US Federal Trade Commission is "fully prepared" to bring forward cases after issuing hundreds of penalty offense notices in April regarding health claims substantiation, and it is likely to seek injunctive and monetary relief, said Samuel Levine, director of the FTC’s Bureau of Consumer Protection, at the National Advertising Division’s annual conference in Philadelphia.
FTC On AI And Consumer Vulnerabilities: ‘One Self-Regulatory Failure Is Begetting Another’
The US FTC’s Sam Levine, director of the Bureau of Consumer Protection, discusses the advent of AI and the compounding risks consumers face in today’s evolving, largely unregulated, profoundly uncertain digital age.
Latest From Legislation & Wellness
Bausch + Lomb Spreads Into US Cosmetics Market, Extends Lumify Brand With Eye Illuminations Line
Canadian firm launches US sales of Lumify Eye Illuminations 3-in-1 Micellar Cleansing Water and Eye Makeup Remover, Nourishing Lash & Brow Serum and Hydra-Gel Brightening Eye Cream. Each product contains hyaluronic acid, a fluid in eyes and joints which acts as a cushion and lubricant.
Good ‘Fit’ For Regulation Shifting US FDA's ODSP Into Larger Food Safety Program – Director
ODSP Director Cara Welch spoke about food programs structure and other supplement industry regulatory news days before first day on the job for agency’s first deputy commissioner for human foods, a post added in the human foods reorganization plan.
Senate Proponents For Tighter Supplement Industry Regulation Question FDA’s Food Programs Overhaul
“We are concerned that these changes could divert resources, funding, and attention from the supplement market at a time when it is needed more than ever,” Democrats Dick Durbin and Richard Blumenthal says in letter to FDA.
Business Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Deals & Wellness
Pierre Fabre Takes Stake In French Women's Health Start-Up
France's Pierre Fabre is enhancing its presence in the women's health market by taking a stake in dietary supplements and cosmetics firm MiYé.
Clasado Adds 14 Markets To Bimuno’s Reach With Phytonet Partnership
A partnership with Swiss functional ingredients supplier Phytonet AG brings UK prebiotic specialist Clasado 14 steps closer to global coverage for Bimuno GOS.
Cipla Grows South African OTC Offering With Actor Acquisition
Cipla has signaled its commitment to expanding its OTC offering with the acquisition of South Africa's Actor Pharma and its diversified consumer health portfolio.
Latest From Business Strategies & Wellness
Message Clear For Xylitol Nasal Spray Firm Xlear: ‘Capitalize’ On FDA’s Oral Phenylephrine Doubts
“Pharmaceuticals have their place, and many do wonderful things for health, but the science of nasal hygiene is clear,” says marketing director Joel Melton.
Why Are UK CBD Brands Pivoting Into Functional Mushroom Supplements?
Ongoing regulatory issues and restrictive marketing rules are prompting CBD brands to pivot to functional mushrooms, the market for which in the UK is predicted to reach a value of £62m by 2025. With both reportedly offering cognitive health benefits, marketing mushrooms and CBD makes good strategic sense, explains Nootro Group CEO Cary Holmes in this HBW Insight deep dive.
US Health And Wellness Executive Decisions: Perrigo, Nestle, Flexpower Health, Herbalife, More
NBA star Antetokounmpo invests in Flexpower; Perrigo changes Americas helm; Bündchen models healthy lifestyle for Gaia; Vit-Best appoints growth chief; Olympian Jennings works with Protein Puck; and more.
Latest From Sales & Earnings & Wellness
DSM-Firmenich Looks To Women's Health and Postbiotics As Immunity Demand Remains Weak
To counteract falling sales due to weaker immunity supplement demand post-pandemic, ingredients firm DSM-Firmenich is investing in innovation in the increasingly popular women's health and postbiotics product categories.
Growth In China Helps Swisse Supplements Hit AU$1bn Sales Milestone
Australian heritage dietary supplements brand Swisse achieved a significant sales milestone in the first half of 2023 reflecting growing demand for its products, particularly in China.
Dermapharm Benefits From Supplements Demand And Arkopharma Acquisition
Germany's Dermapharm said strong global demand for dietary supplements, in combination with its acquisition of herbals specialist Arkopharma, had helped drive up sales in the first half of 2023.
Latest From Legal Issues & Wellness
Message Clear For Xylitol Nasal Spray Firm Xlear: ‘Capitalize’ On FDA’s Oral Phenylephrine Doubts
“Pharmaceuticals have their place, and many do wonderful things for health, but the science of nasal hygiene is clear,” says marketing director Joel Melton.
FTC Health Claims Guidance ‘Lacks Legal Basis,’ Conflicts With FDA’s Supplement Regulations – CRN
“There is no bright-line requirement that a company possess randomized, controlled clinical studies before making so-called ‘health benefit’ claims for dietary supplements,” CRN states in petition. FTC, however, says it “makes no bright-line distinctions between categories of health-related products or claims.”
‘Akin To Junk Mail,’ FTC Notices Of Penalty Offense Don't Identify Health Claim Violations – Petition
Trade group ask FTC to withdraw notices, arguing it is attempting to impose substantiation standard prohibited under FDA regulations for supplement manufacturing and marketing and are inconsistent with its own as well as FDA guidance
Marketing Explore this Topic
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Launches & Wellness
Why Are UK CBD Brands Pivoting Into Functional Mushroom Supplements?
Ongoing regulatory issues and restrictive marketing rules are prompting CBD brands to pivot to functional mushrooms, the market for which in the UK is predicted to reach a value of £62m by 2025. With both reportedly offering cognitive health benefits, marketing mushrooms and CBD makes good strategic sense, explains Nootro Group CEO Cary Holmes in this HBW Insight deep dive.
Bausch + Lomb Spreads Into US Cosmetics Market, Extends Lumify Brand With Eye Illuminations Line
Canadian firm launches US sales of Lumify Eye Illuminations 3-in-1 Micellar Cleansing Water and Eye Makeup Remover, Nourishing Lash & Brow Serum and Hydra-Gel Brightening Eye Cream. Each product contains hyaluronic acid, a fluid in eyes and joints which acts as a cushion and lubricant.
Nestlé Partner Valbiotis Hails Trial Results For Prediabetes Supplement
Valbiotis and Nestlé Health Science plan to launch in 2024 a dietary supplement targeted at sufferers of prediabetes and type-2 diabetes following positive results from a recent study which showed the product's efficacy on key markers of glucose metabolism.
Latest From Ad Campaigns & Wellness
Message Clear For Xylitol Nasal Spray Firm Xlear: ‘Capitalize’ On FDA’s Oral Phenylephrine Doubts
“Pharmaceuticals have their place, and many do wonderful things for health, but the science of nasal hygiene is clear,” says marketing director Joel Melton.
Get To Know: Rising UK Effervescent Wellness Star Phizz
London-based start-up Phizz markets in the UK's busy wellness category effervescent products that it claims effectively hydrate while also providing essential vitamins and minerals.
Over The Counter Special: OTC Marketing Awards Judge On What Makes A Standout Entry, With PAGB's Michelle Riddalls
In this special podcast episode, we speak to PAGB CEO Michelle Riddalls about her role as an OTC Marketing Awards judge and what makes a good entry in her extensive experience. Having spent two decades working in some of the world's largest OTC companies, and now heading up the UK’s OTC industry association which plays an important role in reviewing members' marketing campaigns before they go live, Riddalls is well placed to offer advice to companies working on their entries. Making submissions UK-specific, data-driven but also inclusive of all the creativity that teams bring to a launch or campaign are some of the pointers Riddalls shares with us. Friday 1 September is the entry deadline for the 2023 Awards, which take place at the Royal Lancaster London on Thursday 23 November. If you are interested in entering, head over to Citeline’s 2023 UK OTC Marketing Awards website.
Latest From Ad Complaints & Wellness
Message Clear For Xylitol Nasal Spray Firm Xlear: ‘Capitalize’ On FDA’s Oral Phenylephrine Doubts
“Pharmaceuticals have their place, and many do wonderful things for health, but the science of nasal hygiene is clear,” says marketing director Joel Melton.
FTC Health Claims Guidance ‘Lacks Legal Basis,’ Conflicts With FDA’s Supplement Regulations – CRN
“There is no bright-line requirement that a company possess randomized, controlled clinical studies before making so-called ‘health benefit’ claims for dietary supplements,” CRN states in petition. FTC, however, says it “makes no bright-line distinctions between categories of health-related products or claims.”
MacuHealth Asserts ‘Rigorous Process’ In Research Supporting Claims, But No Bill Of Health From NAD
“MacuHealth believes challenged claims are thoroughly supported by the multitude of peer reviewed, published scientific studies” but NAD review on Vision Elements challenge finds firm’s research doesn’t support its claims.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.